NEW YORK, June 12, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (LUCD) (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback